LENZ Therapeutics, Inc. Revenue 2024–2025
LENZ Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2024 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- LENZ Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 1.9 M.
- LENZ Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 19.4 M.
- LENZ Therapeutics, Inc. annual revenue for 2025 was 19.1 M.
- LENZ Therapeutics, Inc. annual revenue for 2024 was 0.
LENZ Therapeutics, Inc. (LENZ) — Frequently Asked Questions
LENZ Therapeutics, Inc. (LENZ) is a publicly traded US company. It has a market capitalization of $186M. In fiscal 2025 it reported revenue of $19M and net income of -$82M. Explore LENZ's stock price, financial statements, earnings history, margins and key ratios below.
What is LENZ Therapeutics, Inc.'s market cap?
LENZ Therapeutics, Inc. (LENZ) has a market capitalization of $186M.
What is the LENZ stock price?
LENZ trades at $6.45 (-1.98% on the day).
How much revenue does LENZ Therapeutics, Inc. make?
LENZ Therapeutics, Inc. reported revenue of $19M in fiscal 2025.
Is LENZ profitable?
In fiscal 2025, LENZ Therapeutics, Inc. reported net income of -$82M.